| pubmed-article:18454487 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18454487 | lifeskim:mentions | umls-concept:C0037889 | lld:lifeskim |
| pubmed-article:18454487 | lifeskim:mentions | umls-concept:C0011906 | lld:lifeskim |
| pubmed-article:18454487 | lifeskim:mentions | umls-concept:C0039593 | lld:lifeskim |
| pubmed-article:18454487 | lifeskim:mentions | umls-concept:C0022885 | lld:lifeskim |
| pubmed-article:18454487 | lifeskim:mentions | umls-concept:C0520739 | lld:lifeskim |
| pubmed-article:18454487 | lifeskim:mentions | umls-concept:C1317327 | lld:lifeskim |
| pubmed-article:18454487 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:18454487 | pubmed:dateCreated | 2008-6-18 | lld:pubmed |
| pubmed-article:18454487 | pubmed:abstractText | Flow cytometric analysis of eosin-5-maleimide (EMA)-labeled red blood cells (RBCs) has been used as a screening test for the diagnosis of patients with hereditary spherocytosis (HS). We assessed the fluorescence profiles for patients having HS and hereditary pyropoikilocytosis (HPP) together with their red cell indices. | lld:pubmed |
| pubmed-article:18454487 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18454487 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18454487 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18454487 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18454487 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18454487 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18454487 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18454487 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:18454487 | pubmed:issn | 1552-4957 | lld:pubmed |
| pubmed-article:18454487 | pubmed:author | pubmed-author:DhermyDidierD | lld:pubmed |
| pubmed-article:18454487 | pubmed:author | pubmed-author:McMahonCorrin... | lld:pubmed |
| pubmed-article:18454487 | pubmed:author | pubmed-author:DarbyshirePhi... | lld:pubmed |
| pubmed-article:18454487 | pubmed:author | pubmed-author:TelferPaulP | lld:pubmed |
| pubmed-article:18454487 | pubmed:author | pubmed-author:KingMay-JeanM... | lld:pubmed |
| pubmed-article:18454487 | pubmed:author | pubmed-author:MacKinnonHeat... | lld:pubmed |
| pubmed-article:18454487 | pubmed:author | pubmed-author:LangabeerLisa... | lld:pubmed |
| pubmed-article:18454487 | pubmed:copyrightInfo | (c) 2008 Clinical Cytometry Society | lld:pubmed |
| pubmed-article:18454487 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18454487 | pubmed:volume | 74 | lld:pubmed |
| pubmed-article:18454487 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18454487 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18454487 | pubmed:pagination | 244-50 | lld:pubmed |
| pubmed-article:18454487 | pubmed:dateRevised | 2009-12-11 | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:meshHeading | pubmed-meshheading:18454487... | lld:pubmed |
| pubmed-article:18454487 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18454487 | pubmed:articleTitle | Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis. | lld:pubmed |
| pubmed-article:18454487 | pubmed:affiliation | Membrane Biochemistry, International Blood Group Reference Laboratory, Bristol, United Kingdom. may-jean.king@nbs.nhs.uk | lld:pubmed |
| pubmed-article:18454487 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18454487 | pubmed:publicationType | Evaluation Studies | lld:pubmed |
